- Patent Title: 5′ modified nucleosides and oligomeric compounds prepared therefrom
-
Application No.: US16863928Application Date: 2020-04-30
-
Publication No.: US11268094B2Publication Date: 2022-03-08
- Inventor: Thazha P. Prakash , Punit P. Seth , Eric E. Swayze
- Applicant: Ionis Pharmaceuticals, Inc.
- Applicant Address: US CA Carlsbad
- Assignee: Ionis Pharmaceuticals, Inc.
- Current Assignee: Ionis Pharmaceuticals, Inc.
- Current Assignee Address: US CA Carlsbad
- Agency: McNeill Baur PLLC
- Main IPC: C12N15/113
- IPC: C12N15/113 ; C07H19/067 ; C07H19/10 ; C07H21/00

Abstract:
The present invention provides 5′ modified nucleosides and oligomeric compounds prepared therefrom. More particularly, the present invention provides modified nucleosides having at least one 5′-substituent and an optional 2′ substituent, oligomeric compounds comprising at least one of these modified nucleosides and methods of using the oligomeric compounds. In some embodiments, the oligomeric compounds provided herein are expected to hybridize to a portion of a target RNA resulting in loss of normal function of the target RNA.
Information query
IPC分类: